Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Comment on PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Contributors:
      University of Maryland; Imperial College London; Oregon Health and Science University; University of Chester; University of Michigan; University of Southern California; University of Navarra; MD Anderson Cancer Center; University of Newcastle
    • بيانات النشر:
      American Association for the Advancement of Science
    • الموضوع:
      2021
    • Collection:
      University of Chester: Chester Digital Repository
    • نبذة مختصرة :
      This article is not available on ChesterRep. ; LB100 does not sensitize CML stem cells to tyrosine kinase inhibitor–induced apoptosis.
    • ISSN:
      1946-6234
      1946-6242
    • Relation:
      Perrotti, D., Agarwal, A., Lucas, C. M., Narla, G., Neviani, P., Odero, M. D., . & Verrills, N. M. (2019). Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia”. Science translational medicine, 11(501), eaau0416. https://doi.org/10.1126/scitranslmed.aau0416; http://hdl.handle.net/10034/624385; Science Translational Medicine
    • الرقم المعرف:
      10.1126/scitranslmed.aau0416
    • Rights:
      CC0 1.0 Universal ; https://creativecommons.org/licenses/by-nc-nd/4.0/
    • الرقم المعرف:
      edsbas.EBB4A429